allergic reactions to tirzepatide redness at injection site Can Zepbound Cause Redness or Hives at Injection Sites? allergic reaction at injection site

The kidney warnings reflect the potential for indirect effects through volume depletion in susceptible individuals rather than direct nephrotoxicity

July 18, 2025: Chinese Obesity Drug Outperforms Zepbound in Helping Patients Lose Weight, Trials Show A new obesity drug, HRS9531, made by the Chinese company Hengrui Pharma may help patients lose more weight than when on Zepbound

Tirzepatide, a GLP-1/GIP receptor agonist originally developed for type 2 diabetes, induces substantial weight loss, and researchers hypothesized it could alleviate OSA by targeting the underlying obesity

Naltrexone-bupropion is another combination anti-obesity medicine

Compounded tirzepatide salts are a different chemical entity with no published efficacy or safety data